5. References

  1. Drug Enforcement Administration. Federal Register Volume 79, Issue 127 (July 2, 2014). Available at https://www.gpo.gov/fdsys/search/pagedetails.action?st=tramadol&granuleId=2014-15548&packageId=FR-2014-07-02. Accessed December 9th, 2021. 
  2. DRUGDEX® System (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu/. Accessed December 9th, 2021.
  3. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2017. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/.  Accessed December 9th, 2021.
  4. Tramadol tablets (Ultram®) Package Insert. Janssen Pharmaceuticals, September 2021.
  5. Tramadol extended-release capsules (ConZip®) package insert. Vertical Pharmaceuticals, Inc., September 2021.
  6. Tramadol/acetaminophen tablets (Ultracet®) package insert. Janssen Pharmaceuticals, September 2021.
  7. Vorsanger G, Xiang J, Jordan D, Farrell J. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Clin Ther. 2007;29 (Suppl):2520-35.
  8. Barkin RL. Extended-release tramadol (ULTRAM® ER): A pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Am J Ther. 2008;15:157-66.
  9. Cepeda MS, Camargo F, Zea C, Valencia L. Tramadol for osteoarthritis: a systematic review and meta-analysis. J  Rheumatol. 2007;34:543-55.
  10. Leppert W, Luczak J. The role of tramadol in cancer pain treatment--a review. Support Care Cancer. 2005;13:5-17.
  11. Leppert W. Tramadol as an analgesic for mild to moderate cancer pain. Pharmacol Rep. 2009;61:978-92.
  12. Hochbert MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):455-74.
  13. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149-162.
  14. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147:505-14.
  15. Hair PI. Curran MP. Keam SJ. Tramadol extended-release tablets. Drugs. 2006;66:2017-27; discussion 2028-30.
  16. Yates WR, Nguyen MH, Warnock JK. Tramadol dependence with no history of substance abuse. Am J Psychiatry. 2001;158:964.
  17. Miotto K, Cho AK, Khalil MA, et al. Trends in tramadol: pharmacology, metabolism, and misuse. Anesth Analg 2017;124:44–51.
  18. Schug SA. Combination analgesia in 2005 - a rational approach: focus on paracetamol-tramadol. Clin Rheumatol. 2006;25( Suppl 1):S16-21.
  19. Mullican WS, Lacy JR, and the TRAMAP-ANAG-006 Study Group. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial. Clin Ther. 2001;23:1429-45.
  20. Rodriguez RF, Castillo JM, Castillo MP, et al. Hydrocodone/acetaminophen and tramadol chlorhydrate combination tablets for the management of chronic cancer pain: a double-blind comparative trial. Clin J Pain. 2008;24:1-4.
  21. Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3-14.
  22. Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care. 2017;40:136-54.